Tags

Type your tag names separated by a space and hit enter

Deep brain stimulation for Parkinson's disease: Australian referral guidelines.
J Clin Neurosci. 2009 Aug; 16(8):1001-8.JC

Abstract

The advent of deep brain stimulation (DBS) has been an important advance in the treatment of Parkinson's disease (PD). DBS may be employed in the management of medication-refractory tremor or treatment-related motor complications, and may benefit between 4.5% and 20% of patients at some stage of their disease course. In Australia, patients with PD are reviewed by specialised DBS teams who assess the likely benefits and risks associated with DBS for each individual. The aim of these guidelines is to assist neurologists and general physicians identify patients who may benefit from referral to a DBS team. Common indications for referral are motor fluctuations and/or dyskinesias that are not adequately controlled with optimised medical therapy, medication-refractory tremor, and intolerance to medical therapy. Early referral for consideration of DBS is recommended as soon as optimised medical therapy fails to offer satisfactory motor control.

Authors+Show Affiliations

North Shore Private Hospital, Sydney, New South Wales, Australia. paul@silberstein.com.auNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Practice Guideline
Research Support, Non-U.S. Gov't
Review

Language

eng

PubMed ID

19596113

Citation

Silberstein, Paul, et al. "Deep Brain Stimulation for Parkinson's Disease: Australian Referral Guidelines." Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, vol. 16, no. 8, 2009, pp. 1001-8.
Silberstein P, Bittar RG, Boyle R, et al. Deep brain stimulation for Parkinson's disease: Australian referral guidelines. J Clin Neurosci. 2009;16(8):1001-8.
Silberstein, P., Bittar, R. G., Boyle, R., Cook, R., Coyne, T., O'Sullivan, D., Pell, M., Peppard, R., Rodrigues, J., Silburn, P., Stell, R., & Watson, P. (2009). Deep brain stimulation for Parkinson's disease: Australian referral guidelines. Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia, 16(8), 1001-8. https://doi.org/10.1016/j.jocn.2008.11.026
Silberstein P, et al. Deep Brain Stimulation for Parkinson's Disease: Australian Referral Guidelines. J Clin Neurosci. 2009;16(8):1001-8. PubMed PMID: 19596113.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Deep brain stimulation for Parkinson's disease: Australian referral guidelines. AU - Silberstein,Paul, AU - Bittar,Richard G, AU - Boyle,Richard, AU - Cook,Raymond, AU - Coyne,Terry, AU - O'Sullivan,Dudley, AU - Pell,Malcolm, AU - Peppard,Richard, AU - Rodrigues,Julian, AU - Silburn,Peter, AU - Stell,Rick, AU - Watson,Peter, AU - ,, PY - 2008/04/26/received PY - 2008/11/09/revised PY - 2008/11/10/accepted PY - 2009/7/15/entrez PY - 2009/7/15/pubmed PY - 2009/9/24/medline SP - 1001 EP - 8 JF - Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia JO - J Clin Neurosci VL - 16 IS - 8 N2 - The advent of deep brain stimulation (DBS) has been an important advance in the treatment of Parkinson's disease (PD). DBS may be employed in the management of medication-refractory tremor or treatment-related motor complications, and may benefit between 4.5% and 20% of patients at some stage of their disease course. In Australia, patients with PD are reviewed by specialised DBS teams who assess the likely benefits and risks associated with DBS for each individual. The aim of these guidelines is to assist neurologists and general physicians identify patients who may benefit from referral to a DBS team. Common indications for referral are motor fluctuations and/or dyskinesias that are not adequately controlled with optimised medical therapy, medication-refractory tremor, and intolerance to medical therapy. Early referral for consideration of DBS is recommended as soon as optimised medical therapy fails to offer satisfactory motor control. SN - 0967-5868 UR - https://www.unboundmedicine.com/medline/citation/19596113/Deep_brain_stimulation_for_Parkinson's_disease:_Australian_referral_guidelines_ L2 - https://linkinghub.elsevier.com/retrieve/pii/S0967-5868(09)00221-5 DB - PRIME DP - Unbound Medicine ER -